Understanding Lymphoma
Hodgkin's lymphoma is a malignancy of lymphocytes, which are immune system cells.
There are two forms of lymphoma:
Hodgkin’s lymphoma, often known as Hodgkin's disease
Non-Hodgkin lymphoma (NHL), a type of cancer that affects the lymphatic system
Lymphoma is the most frequent cancer among teenagers aged 15 to 19. The prognosis for each patient varies, although Hodgkin’s disease may usually be treated and managed.
Survival Rates
If detected early, Hodgkin's and non-Hodgkin’s disease are regarded as one of the most curable cancers in small intestine. The overall relative survival rates for NHL are 69 percent and 59 percent, respectively, after five and ten years. Survival statistics for Hodgkin's lymphoma are usually better, with an 85 percent five-year survival rate and an 80 percent 10-year survival rate. Many factors can influence a patient's prognosis and survival probability, including:
Patient's age - Being under 60 years old can help you have a better outlook because you are more likely to battle sickness.
Stage of disease - Stages I and II can have a favorable prognosis, while later stages may also be highly curable.
There is no lymphoma outside of lymph nodes, or there is lymphoma in only one place outside of lymph nodes.
Performance status - Ability to function regularly; scored on a scale of zero to one hundred (100 meaning you are at normal health).
Lactate dehydrogenase (LDH) levels in the blood are abnormally high. When cells are injured or destroyed, the LDH enzyme is released.
Small Intestinal Lymphoma/Cancer Treatment Alternatives
Hodgkin and non-Hodgkin lymphoma therapy choices are largely similar to other types of cancer treatment. Despite the fact that the categories are similar, your treatment strategy may differ significantly based on what your small intestinal cancer treatment specialist suggests. One or more of the following treatments may be used:
Radiation therapy
Chemotherapy
Transplantation of stem cells
Targeted therapy
Immunotherapy
0 Comments